Annual CFI
-$36.00 K
+$450.00 K+92.59%
December 31, 2024
Summary
- As of March 13, 2025, XLO annual cash flow from investing activities is -$36.00 thousand, with the most recent change of +$450.00 thousand (+92.59%) on December 31, 2024.
- During the last 3 years, XLO annual CFI has risen by +$1.06 million (+96.73%).
- XLO annual CFI is now at all-time high.
Performance
XLO Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$6000.00
+$3000.00+33.33%
December 31, 2024
Summary
- As of March 13, 2025, XLO quarterly cash flow from investing activities is -$6000.00, with the most recent change of +$3000.00 (+33.33%) on December 31, 2024.
- Over the past year, XLO quarterly CFI has dropped by -$6000.00 (-100.00%).
Performance
XLO Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$36.00 K
-$6000.00-20.00%
December 31, 2024
Summary
- As of March 13, 2025, XLO TTM cash flow from investing activities is -$36.00 thousand, with the most recent change of -$6000.00 (-20.00%) on December 31, 2024.
- Over the past year, XLO TTM CFI has increased by +$450.00 thousand (+92.59%).
- XLO TTM CFI is now -71.43% below its all-time high of -$21.00 thousand, reached on June 30, 2024.
Performance
XLO TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
XLO Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +92.6% | -100.0% | +92.6% |
| 3 y3 years | +96.7% | -100.0% | +92.6% |
| 5 y5 years | +95.0% | -100.0% | +92.6% |
XLO Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +98.1% | <-9999.0% | +99.2% | -71.4% | +98.1% |
| 5 y | 5-year | at high | +98.3% | <-9999.0% | +99.2% | -71.4% | +98.1% |
| alltime | all time | at high | +98.3% | <-9999.0% | +99.2% | -71.4% | +98.1% |
Xilio Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$36.00 K(-92.6%) | -$6000.00(-33.3%) | -$36.00 K(+20.0%) |
| Sep 2024 | - | -$9000.00(-57.1%) | -$30.00 K(+42.9%) |
| Jun 2024 | - | -$21.00 K(<-9900.0%) | -$21.00 K(-93.4%) |
| Mar 2024 | - | $0.00(0.0%) | -$316.00 K(-35.0%) |
| Dec 2023 | -$486.00 K(-74.0%) | $0.00(0.0%) | -$486.00 K(-51.2%) |
| Sep 2023 | - | $0.00(-100.0%) | -$995.00 K(-25.1%) |
| Jun 2023 | - | -$316.00 K(+85.9%) | -$1.33 M(-25.5%) |
| Mar 2023 | - | -$170.00 K(-66.6%) | -$1.78 M(-4.5%) |
| Dec 2022 | -$1.87 M | -$509.00 K(+52.9%) | -$1.87 M(+7.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$333.00 K(-56.8%) | -$1.74 M(+14.4%) |
| Jun 2022 | - | -$771.00 K(+203.5%) | -$1.52 M(+28.1%) |
| Mar 2022 | - | -$254.00 K(-32.8%) | -$1.18 M(+7.6%) |
| Dec 2021 | -$1.10 M(-49.7%) | -$378.00 K(+231.6%) | -$1.10 M(+52.4%) |
| Sep 2021 | - | -$114.00 K(-74.0%) | -$722.00 K(+18.8%) |
| Jun 2021 | - | -$438.00 K(+157.6%) | -$608.00 K(+257.6%) |
| Mar 2021 | - | -$170.00 K | -$170.00 K |
| Dec 2020 | -$2.19 M(+206.0%) | - | - |
| Dec 2019 | -$715.00 K | - | - |
FAQ
- What is Xilio Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Xilio Therapeutics?
- What is Xilio Therapeutics annual CFI year-on-year change?
- What is Xilio Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Xilio Therapeutics?
- What is Xilio Therapeutics quarterly CFI year-on-year change?
- What is Xilio Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Xilio Therapeutics?
- What is Xilio Therapeutics TTM CFI year-on-year change?
What is Xilio Therapeutics annual cash flow from investing activities?
The current annual CFI of XLO is -$36.00 K
What is the all time high annual CFI for Xilio Therapeutics?
Xilio Therapeutics all-time high annual cash flow from investing activities is -$36.00 K
What is Xilio Therapeutics annual CFI year-on-year change?
Over the past year, XLO annual cash flow from investing activities has changed by +$450.00 K (+92.59%)
What is Xilio Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of XLO is -$6000.00
What is the all time high quarterly CFI for Xilio Therapeutics?
Xilio Therapeutics all-time high quarterly cash flow from investing activities is $0.00
What is Xilio Therapeutics quarterly CFI year-on-year change?
Over the past year, XLO quarterly cash flow from investing activities has changed by -$6000.00 (-100.00%)
What is Xilio Therapeutics TTM cash flow from investing activities?
The current TTM CFI of XLO is -$36.00 K
What is the all time high TTM CFI for Xilio Therapeutics?
Xilio Therapeutics all-time high TTM cash flow from investing activities is -$21.00 K
What is Xilio Therapeutics TTM CFI year-on-year change?
Over the past year, XLO TTM cash flow from investing activities has changed by +$450.00 K (+92.59%)